Purchase Order HHSF223201510540A
- Not listed
- This is a $266,000.00 Firm Fixed Price Purchase Order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Caitta Inc., an SBA-certified Economically Disadvantaged Women-Owned Small Business (EDWOSB) and 8(a) program participant. The contract is for a "Precedent Based Approach to Support Decision-Making Oncology", and was awarded as an 8(a) Sole Source contract. Caitta Inc. is a federal contractor that specializes in providing scientific, technical, and...
- This is a $190,800 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract is for knowledge management services. Caitta Inc. specializes in providing scientific, technical, and administrative services to federal health and research agencies, with expertise in supplying sophisticated scientific and...
- This federal contract award was made by the Food and Drug Administration (FDA), a civilian agency, to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The $132,000 Firm Fixed Price Purchase Order is for business process improvement quality services to support the FDA's 21st Century initiatives. The contract has an 8(a) sole source set-aside designation. Caitta Inc. is a federal contractor that specializes in providing...
- This is a $442,329.37 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract is for drug shortage support services for the FDA's Office of Generic Drugs. The contract has an ultimate completion date of May 31, 2020 and was awarded on May 29, 2015. Caitta Inc. is a federal contractor that specializes in providing scientific,...
- This is a $238,950.95 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract is for RESEARCH SUPPORT FOR OSIS, with an ultimate completion date of September 27, 2016. Caitta Inc. has a diverse portfolio of federal contracts, including a $2 million GSA Federal Supply Schedule contract and a $999,000 multiple-award contract with the...
- This is a $149,470.00 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract is not set aside. The purpose of this effort is to integrate compliance within an existing quality management system (QMS) for regulating pharmaceutical quality. The contract does not involve information technology/systems development. Caitta Inc....
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant, for PROJECT RESEARCHER SUPPORT services. The contract has a ceiling value of $336,595.10 and an ultimate completion date of September 27, 2017. Caitta Inc. is a federal contractor that specializes in providing scientific, technical, and administrative services...
- The Department of Health and Human Services Food and Drug Administration awarded a $217,346.52 firm fixed price purchase order to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The award is for contractor support services, with a performance period ending on May 3, 2023. Caitta has a history of providing scientific, technical, and administrative services to HHS and its agencies, including the FDA, NIH, and NIST, through both competitive awards and...
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB). The contract is for $1,518,064.70 and has an ultimate completion date of July 24, 2028. The contract is for a "Small Dispensers Assessment and Business Process Improvement (BPI) to Establish a Quality Management System (QMS)." Caitta Inc. is a strategic federal...
- This is a firm fixed price contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The contract is for the FDA's Center for Drug Evaluation and Research (CDER) Office of Compliance (OC) Compounding Program Business Process Improvement (BPI) and Quality Management System, with a completion date of August 15, 2024 and a potential value of $881,893.55. Caitta...
This is a $301,014.00 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract supports a precedent-based approach to decision-making and the development of a maturity model for pharmaceutical quality system assessment. This award is a sole source contract set aside for 8(a) companies. Caitta Inc. specializes in providing scientific, technical, and administrative services to federal health and research agencies, with a focus on delivering advanced scientific instrumentation, analytical equipment, and professional support services. The company holds a $2 million Federal Supply Schedule contract with the General Services Administration (GSA) and has been awarded various other indefinite delivery vehicle (IDV) contracts, demonstrating its strategic positioning and versatility within the federal contracting ecosystem.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $301.0k | 9/8/15 |